Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD + synthesis via enterohepatic circulation
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 35 of the 44 sources its claims cite were checked for support.
Abstract
This study found that orally and intravenously administered NMN and NR undergo degradation pathways including conversion to nicotinamide and deamidation to nicotinic acid-related metabolites.
Overview
CoChat Summary
## TL;DR
In mice, orally administered NMN and NR were only partly directly absorbed; most were converted by gut microbiota into nicotinic acid and then used to make NAD+ in the liver via the Preiss-Handler pathway. The study also found that intravenously administered NMN and NR were degraded to nicotinamide, secreted into bile, converted by gut microbiota, and routed back through enterohepatic circulation.
## Key findings
- After oral gavage, NMN significantly increased NMN levels in the small intestine at 15 min, while NR produced a much smaller rise, about 25-fold less than NMN; small-intestine NAD+ peaked at 15–30 min.
- In WT mice, oral NMN and NR increased hepatic deamidated metabolites (NAAD, NAMN, NAR) at 3–6 hours; in germ-free mice, these deamidated metabolites did not increase and hepatic NAD+ rise was significantly suppressed.
- In Naprt KO mice, oral NMN failed to increase hepatic NAAD, NAMN, and NAR, and hepatic NAD+ rise was significantly suppressed, showing that NMN-derived NAD+ synthesis in the liver depends mainly on the Preiss-Handler pathway.
- Stable-isotope tracing showed that orally administered [m+6] NR and [m+8] NMN produced only small amounts of labeled NAD+, while most increased NAD+ in liver and skeletal muscle was labeled as [m+1], [m+3], or [m+4], consistent with conversion through NAM/NA rather than direct precursor use.
- After intravenous injection, NR and NMN increased liver and skeletal muscle NAD+ at 3 hours, but antibiotic treatment abolished the rise in NAAD, NAMN, and NAR and reduced liver NAD+, indicating a gut microbiota contribution even for injected precursors; bile duct ligation significantly suppressed hepatic NAAD and reduced NMN-driven liver NAD+ (with P = 0.0533 for an interaction trend).
## Methods
- Mouse in vivo metabolomics study using WT C57BL/6N, germ-free, Naprt KO, and antibiotic-treated mice; interventions included single oral gavage, 2-week repeated gavage, intravenous injection, and bile duct ligation.
- Doses included 1.57 mmol/kg NR chloride or NMN for single gavage/injection; repeated gavage used 131 mg/kg NMN for 2 weeks.
- Main analysis was NAD+ metabolomics by LC-MS/MS in liver, skeletal muscle (gastrocnemius), small intestine, large intestine, serum, bile, and portal blood, plus stable-isotope tracing with [m+6] NR, [m+8] NMN, and [m+4] NAM.
## Limitations
- The paper states that it remains unknown whether the route of secretion from blood to the gastrointestinal tract is via bile and that the detailed mechanisms of NAM/NR transport into bile are unknown.
- The paper states that it remains unclear whether human in vivo NAD+ metabolism is the same as in mice.
- The paper states that the contribution of direct NAD+ synthesis from NR or NMN during long-term administration remains unknown; evident from the text: several conclusions are based on mouse models and short time windows after dosing, so translation to humans and chronic use is not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3. Tracing of orally administered stable isotope–labeled NMN and NR revealed that NAD+ synthesis through gut microbiota and Preiss-Handler pathway was the major route in the liver. (A) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 6] NR. (B) NAD+ metabolome in the liver of WT mice at 3 hours after the oral administration of [m + 6] NR. n = 5 mice for saline group and n = 4 mice for NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (C) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 8] NMN. (D) NAD+ metabolome in the liver of WT mice at 3 hours after the oral administration of [m + 8] NMN. n = 5 mice for saline group and n = 4 mice for NMN-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).](https://figures.cochat.ai/paper-figures/226944274b4e41b495540938d0671c7b/nicotinamide-riboside-and-nicotinamide-mononucleotide-facilitate-nad-sup-sup-figure-3.jpg)
![Fig. 4. NAM cleaved from orally administered NR and NMN was preferentially used for NAD+ synthesis in the skeletal muscle. (A) Time course analysis of muscle NAD+ metabolome in mice gavaged with NMN and NR. n = 6 mice per group. P values of interaction effect; NAD+ < 0.0001, NR < 0.0001, NMN = 0.0020, NAM = 0.0002, NAAD < 0.0001, NAR < 0.0001, NAMN < 0.0001, and NA = 0.1543. Statistical significance was determined by Tukey’s test. Asterisks (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001) indicate significance versus the saline group at the same time point in the overall analysis, while daggers (†P < 0.05) indicate significance in the specific time point analysis. (B) Muscle NAD+ metabolome in mice at 3 hours after the oral administration of [m + 6] NR. n = 5 (saline group) and n = 4 (NR group). Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (C) Muscle NAD+ metabolome in mice at 3 hours after the oral administration of [m + 8] NMN. n = 5 (saline group) and n = 4 (NMN group). Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (D) Muscle NAD+ metabolome in WT and Naprt KO mice at 3 hours after the oral administration of NMN and NR. n = 4 to 6 mice per group. P values of interaction effect; NAD+ = 0.5991, NR = 0.7034, NMN = 0.6969, NAM = 0.9819, NAAD < 0.0001, NAR < 0.0001, and NA = 0.0885. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).](https://figures.cochat.ai/paper-figures/62f670a01f0041569728b62676a5aeb8/nicotinamide-riboside-and-nicotinamide-mononucleotide-facilitate-nad-sup-sup-figure-4.jpg)

![Fig. 6. NR is taken up by muscle and partially contributes to NAD+ synthesis. (A) NAD+ metabolome in muscle at 30 and 180 min after intravenous injection of nonlabeled NR. n = 4 mice for 30 min and n = 5 mice for 180 min. NAD+ = 0.0055, NR = 0.0078, NMN = 0.0960, NAM = 0.0187, NAAD = 0.0003, NAR = 0.4023, NAMN = 0.3484, and NA = 0.0604. Statistical significance was determined by Tukey’s test (*P < 0.05, **P < 0.01, and ****P < 0.0001). (B) Scheme of formation of stable isotope–labeled NAD+ metabolites after the oral administration of [m + 8] NR. (C) NAD+ metabolome in the liver at 30 min after intravenous injection of [m + 8] NR. n = 5 mice for the control group and n = 6 mice for the NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (D) NAD+ metabolome in the muscle at 30 min after intravenous injection of [m + 8] NR. n = 5 mice for the control group and n = 6 mice for the NR-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001).](https://figures.cochat.ai/paper-figures/36c6157d47b84a5db050d2879acc6267/nicotinamide-riboside-and-nicotinamide-mononucleotide-facilitate-nad-sup-sup-figure-6.jpg)
![Fig. 7. Enterohepatic circulation of NAD+ precursors was important for NAD+ synthesis in the liver. (A) NAD+ metabolome in the bile of WT mice under normal conditions. n = 8 mice. (B) NAD+ metabolome in the bile of WT mice at 30 min after the intravenous injection of NMN and NR. n = 8 to 10 mice per group. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (C) Scheme of formation of stable isotope–labeled NAD+ metabolites after the intravenous injection of [m + 4] NAM. (D) NAD+ metabolome in the liver of WT mice at 30 min after the intravenous injection of [m + 4] NAM. n = 8 mice for saline group and n = 11 mice for NAM-treated group. Statistical significance was determined by Student’s t test (****P < 0.0001). (E) NAD+ metabolome in the bile of WT mice at 30 min after the intravenous injection of [m + 4] NAM. n = 8 mice for the saline group and n = 10 mice for the NAM-treated group. Statistical significance was determined by Student’s t test (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (F) NAD+ metabolome in the liver of sham- and bile duct ligation (BDL)–operated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NAD+ = 0.0533 and NAAD = 0.0201. Statistical significance was determined by Tukey’s test (*P < 0.05 and **P < 0.01). (G) NAD+ levels in the skeletal muscle of sham- and BDL-operated mice at 3 hours after the intravenous injection of NMN and NR. n = 6 to 9 mice per group. P values of interaction effect; NAD+ = 0.3869. Statistical significance was determined by Tukey’s test.](https://figures.cochat.ai/paper-figures/01bdfe82e51c4f2faf09e43fcf539131/nicotinamide-riboside-and-nicotinamide-mononucleotide-facilitate-nad-sup-sup-figure-7.jpg)

Verification
Claims the paper makes
20 Valid · 3 Not valid · 1 Not checked · 149 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Most bacteria have a NAM deamidase, an enzyme that converts NAM into NA.”
§ Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation > INTRODUCTION
What the sources say
- Not checked — no full text of the sourcecites [12] P. Belenky, K. C. Christensen, F. Gazzaniga, A. A. Pletnev, C. Brenner, Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for Urh1 and purine nucleoside phosphorylase function in NAD+ metabolism. J. Biol. Chem. 284, 158– 164 (2009). 19001417 PMC2610512 source
- Supportedcites [25] F. Gazzaniga, R. Stebbins, S. Z. Chang, M. A. McPeek, C. Brenner, Microbial NAD metabolism: Lessons from comparative genomics. Microbiol. Mol. Biol. Rev. 73, 529– 541 (2009). 19721089 PMC2738131 source
The Introduction says bacterial pncA genes, which encode nicotinamidase, are more common than the alternative nadV genes and reports pncA in a majority of the sequenced bacteria it lists across several groups. It also states that nicotinamidases convert nicotinamide (NAM) to nicotinic acid (NA). (LLM, conf=0.87)
- Partly supportedcites [26] G. Wang, E. Pichersky, Nicotinamidase participates in the salvage pathway of NAD biosynthesis in Arabidopsis. Plant J. 49, 1020– 1029 (2007). 17335512 sourceExperimental — accuracy not yet measured
The introduction (page unavailable) says that in bacteria and yeast, nicotinamidase converts nicotinamide (NAM) to nicotinic acid (NA). It does not establish that most bacterial species have the enzyme. (LLM, conf=0.82)
- Disputedcites [27] M. Di Stefano, I. Nascimento-Ferreira, G. Orsomando, V. Mori, J. Gilley, R. Brown, L. Janeckova, M. E. Vargas, L. A. Worrell, A. Loreto, J. Tickle, J. Patrick, J. R. Webster, M. Marangoni, F. M. Carpi, S. Pucciarelli, F. Rossi, W. Meng, A. Sagasti, R. R. Ribchester, G. Magni, M. P. Coleman, L. Conforti, A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ. 22, 731– 742 (2015). 25323584 PMC4392071 sourceExperimental — accuracy not yet measured
The Results section (“Genetic data confirm that NMN and NAMPT are necessary for rapid Wallerian degeneration”; page unavailable) says many bacterial species have an NMN deamidase that converts NMN to NaMN. The claim instead names NAM deamidase, gives NAM to NA as its reaction, and says “most” rather than “many” bacteria. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [28] S. Feng, L. Guo, H. Wang, S. Yang, H. Liu, Bacterial PncA improves diet-induced NAFLD in mice by enabling the transition from nicotinamide to nicotinic acid. Commun. Biol. 6, 235 (2023). 36864222 PMC9981684 sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says bacterial PncA catalyzes the conversion of NAM to NA. The Results (page unavailable) describe PncA as highly conserved across different bacterial phyla, but do not establish that most bacterial species have it. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Meanwhile, NR is converted to NMN by NR kinase (NRK), thereby bypassing the NAMPT-mediated step (11, 12).”
§ Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation > INTRODUCTION
What the sources say
- Supportedcites [11] J. Ratajczak, M. Joffraud, S. A. Trammell, R. Ras, N. Canela, M. Boutant, S. S. Kulkarni, M. Rodrigues, P. Redpath, M. E. Migaud, J. Auwerx, O. Yanes, C. Brenner, C. Cantó, NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat. Commun. 7, 13103 (2016). 27725675 PMC5476803 source
The Abstract (page unavailable) states that NR kinases phosphorylate NR to NMN. The Results section, “Extracellular conversion of NMN to NR by hepatic cells” (page unavailable), explicitly says the NRK pathway bypasses NAMPT and that NR can be metabolized to NAD+ independently of NAMPT. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [12] P. Belenky, K. C. Christensen, F. Gazzaniga, A. A. Pletnev, C. Brenner, Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for Urh1 and purine nucleoside phosphorylase function in NAD+ metabolism. J. Biol. Chem. 284, 158– 164 (2009). 19001417 PMC2610512 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“As NR-derived NAM reached the large intestine, the gut microbiota deamidated NAM into NA.”
§ Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation > INTRODUCTION
What the sources say
- Supportedcites [22] K. Yaku, S. Palikhe, H. Izumi, T. Yoshida, K. Hikosaka, F. Hayat, M. Karim, T. Iqbal, Y. Nitta, A. Sato, M. E. Migaud, K. Ishihara, H. Mori, T. Nakagawa, BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. Nat. Commun. 12, 6767 (2021). 34799586 PMC8604996 source
The Discussion’s Fig. 10 caption states that NR is degraded to NAM in the small intestine and that NR-derived NAM is then metabolized to NA by gut microbiota in the large intestine. This directly supports the attributed pathway. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Subsequently, NA was absorbed from the large intestine and contributed to NAD+ synthesis in the liver through the Preiss-Handler pathway in the late phase (approximately 3 hours after oral administration).”
§ Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation > INTRODUCTION
What the sources say
- Supportedcites [22] K. Yaku, S. Palikhe, H. Izumi, T. Yoshida, K. Hikosaka, F. Hayat, M. Karim, T. Iqbal, Y. Nitta, A. Sato, M. E. Migaud, K. Ishihara, H. Mori, T. Nakagawa, BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. Nat. Commun. 12, 6767 (2021). 34799586 PMC8604996 source
The Introduction states that microbiota-derived NA can be absorbed from the large intestine and enter the Preiss–Handler pathway. The Discussion reports that, about 3 hours after oral NR administration, NR-derived NA contributes to liver NAD+ synthesis through that pathway. The paper’s experiments were in mice. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent studies indicated that the gut microbiota is essentially involved in the host NAD+ metabolism network (22–24).”
§ Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation > INTRODUCTION
What the sources say
- Partly supportedcites [22] K. Yaku, S. Palikhe, H. Izumi, T. Yoshida, K. Hikosaka, F. Hayat, M. Karim, T. Iqbal, Y. Nitta, A. Sato, M. E. Migaud, K. Ishihara, H. Mori, T. Nakagawa, BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities. Nat. Commun. 12, 6767 (2021). 34799586 PMC8604996 sourceExperimental — accuracy not yet measured
The Results section, “Gut microbiota is involved in late phase NAD+ synthesis from NR” (page not provided), shows that depleting gut microbiota suppressed the late-phase NAD+ increase after oral NR in mice. It also reports that early-phase NAD+ repletion was unaffected, so the paper supports a role in a specific pathway, not an essential role across the host NAD+ metabolism network. (LLM, conf=0.86)
- Supportedcites [23] I. Shats, J. G. Williams, J. Liu, M. V. Makarov, X. Wu, F. B. Lih, L. J. Deterding, C. Lim, X. Xu, T. A. Randall, E. Lee, W. Li, W. Fan, J. L. Li, M. Sokolsky, A. V. Kabanov, L. Li, M. E. Migaud, J. W. Locasale, X. Li, Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway. Cell Metab. 31, 564– 579.e7 (2020). 32130883 PMC7194078 source
The Introduction describes a host–microbe interaction that enhances mammalian NAD biosynthesis, and the Results report that gut microbiota-mediated processing contributes substantially to NAD synthesis after supplementation. The Results also note that hepatic NAD metabolism was not affected by microbiota under regular feeding, so the finding should not be read as dependence in every condition. (LLM, conf=0.88)
- Supportedcites [24] K. Chellappa, M. R. McReynolds, W. Lu, X. Zeng, M. Makarov, F. Hayat, S. Mukherjee, Y. R. Bhat, S. R. Lingala, R. T. Shima, H. C. Descamps, T. Cox, L. Ji, C. Jankowski, Q. Chu, S. M. Davidson, C. A. Thaiss, M. E. Migaud, J. D. Rabinowitz, J. A. Baur, NAD precursors cycle between host tissues and the gut microbiome. Cell Metab. 34, 1947– 1959.e5 (2022). 36476934 PMC9825113 source
The Introduction describes host-derived NAM feeding microbial NAD synthesis and the microbiome converting it into NA that host tissues can use to regenerate NAD. The Discussion identifies this as a bidirectional vitamin B3 cycle between host and microbes, supporting the claim that gut microbiota participate in host NAD+ metabolism. (LLM, conf=0.93)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
118 more claims · 8 with their cited sources checked
Create a free account to see all 173 claims and every source verdict.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 41
- Borderline: one of the tests for a substantial claim is unclear. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation > Abstract
“These findings showed that NMN and NR are indirectly converted to NAD+ via unexpected metabolic pathways.”
§ Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation > DISCUSSION
“In the present study, we comprehensively analyzed the NAD+ synthesis pathways of orally and intravenously administered NMN and NR, demonstrating that most of NMN and NR were direct precursors of NAD+ (Fig. 8).”
Citations
Cites
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340 · cited 1×
“…preclinical and clinical studies have demonstrated that NMN and NR administration provides beneficial effects, especially against metabolic dysfunctions and age-associated diseases, including obesity, insulin resistance, neurodegenerative diseases, and age-related decline in fertility ( 13 – 19 ).”
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255 · cited 1×
“The skeletal muscle is considered an important target organ for NAD + replenishment therapy ( 34 – 36 ).”
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061 · cited 2×
“Recently, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have attracted increasing interest as alternative NAD + precursors ( 4 , 9 ).”
Revollo, J. R., Grimm, A. A., & Imai, S.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408388200 · Cited by 1,010 · cited 2×
“NMN is a substrate for nicotinamide mononucleo-tide adenylyltransferase (NMNAT), which is an enzyme that converts NMN and adenosine triphosphate to NAD + and inorganic pyrophosphate ( 10 ).”
Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930 · cited 1×
“However, the increase of NAD + levels in the skeletal muscle after NR and NMN administration is not as efficient as that in the liver ( 17 , 18 , 20 , 39 – 42 ).”
Self-citationCamacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865 · cited 2×
“Recently, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have attracted increasing interest as alternative NAD + precursors ( 4 , 9 ).”
Bieganowski, P., & Brenner, C. (2004) · Cell · doi:10.1016/s0092-8674(04)00416-7 · Cited by 750 · cited 1×
“They are also abundant in human breast milk and cow’s milk ( 45 – 47 ).”
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016) · Nature Communications · doi:10.1038/ncomms12948 · Cited by 697 · cited 1×
“A previous study proposed that orally administered NR was directly absorbed from the intestine as an intact form and converted to NMN by NRK inside cells ( 11 , 60 ).”
Self-citation
Cited by
NAD+ precursor supplementation in human ageing: clinical evidence and challenges
Vinten, K. T., Trętowicz, M. M., Coskun, E., van Weeghel, M., Cantó, C., Perez, R. Z., Janssens, G. E., & Houtkooper, R. H. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01387-7 · Cited by 44
“However, more recently, SLC12A8 has been described as a potential NMN transporter 63,64 , although this finding remains controversial 65 .”
Christen, S., Redeuil, K. M., Goulet, L., Giner, M. P., Breton, I., Rota, R., Frézal, A., Nazari, A., den Abbeele, P. V., Godin, J., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01421-8 · Cited by 32
“Moreover, the oral bioavailability of polar and charged nucleotides and nucleosides similar to NR and NMN is notoriously poor 25 , and recent studies in rodents suggest that a substantial part of the NAD + -boosting effect of NR and NMN is mediated via their microbial conversion to NA 26–30 .”
Gut Microbiota and Dietary Strategies for Age‐Related Diseases
Upadhyay, P., Kumar, S., Chellammal, H. S. J., Sahu, N., Srivastava, S., Kumar, R., & Gasmi, A. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70308 · Cited by 16
“Similarly, gut microbiota-mediated deamidation of orally administered NAD + precursors such as nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) generates nicotinic acid, which is preferentially utilized by the liver for NAD + replenishment and systemic metabolic health [137].”
Visalli, F., Capobianco, M., Cappellani, F., Rapisarda, L., Spinello, A., Avitabile, A., Cannizzaro, L., Gagliano, C., & Zeppieri, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010485 · Cited by 17
Tang, M., Outissint, I., Chen, Y., & Gong, X. (2025) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70056 · Cited by 16
“D ‐ ribofuranoside 5 ′‐ phosphate, serves as an essential intermediate in the biosynthesis of NAD + and is a biologically active nucleotide [291 – 293].”
Metadata
- Authors
- Yaku, K., Palikhe, S., Iqbal, T., Hayat, F., Watanabe, Y., Fujisaka, S., Izumi, H., Yoshida, T., Karim, M., Uchida, H., Nawaz, A., Tobe, K., Mori, H., Migaud, M. E., & Nakagawa, T.
- Affiliations
- University of Toyama (JP)
- USA Mitchell Cancer Institute (US)
- Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama, Toyama 930-0194, Japan.
- Corresponding author
- Yaku, Keisuke
- Palikhe, Sailesh
- Nakagawa, Takashi
- ORCID
- Venue
- Science Advances
- Published
- 2025-03-21
- Volume
- 11
- Issue
- 12
- Pages
- eadr1538-eadr1538
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC11927621
- OpenAlex
- W4408718208
- Cited by
- 40
- References
- 65
- Citations by year
- 2026: 30 · 2025: 10
- FWCI
- 23.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, cc-by-nc)
- Funders
- Japan Society for the Promotion of Science (23K24762, 23K09644)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Keywords
- nicotinamide riboside, nicotinamide mononucleotide, NAD+ synthesis, enterohepatic circulation, gut microbiota, deamidation, nicotinic acid, NAD+ precursors, oral and intravenous administration, aging, bile secretion, nicotinamide
- MeSH terms
- Gastrointestinal Microbiome, Administration, Oral, Animals, Liver, Male, Mice, Inbred C57BL, NAD, Niacinamide, Nicotinamide Mononucleotide, Pyridinium Compounds, Mice, Metabolomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.